Search results
Results from the WOW.Com Content Network
The most prevalent research on prescription drugs with side effects of macropsia deals with zolpidem and citalopram. Zolpidem is a drug prescribed for insomnia, and although it has proven beneficial effects, there have been numerous reported cases of adverse perceptual reactions. [ 13 ]
Vision loss in toxic and nutritional optic neuropathy is bilateral, symmetric, painless, gradual, and progressive. Dyschromatopsia, a change in color vision, is often the first symptom. Some patients notice that certain colors, particularly red, are less bright or vivid; others have a general loss of color perception.
Corticosteroids (for optic neuritis), other medications depending on the cause: Prognosis: Variable; some cases recover, others lead to permanent vision loss: Frequency: Common in individuals with risk factors (e.g., older adults, smokers) Deaths: None directly from optic neuropathy, but complications from underlying causes (e.g., stroke) can ...
Few medications have gotten as much attention as semaglutide.The injectable drug, which is sold under the brand names Wegovy and Ozempic, is FDA-approved to help with weight loss and type 2 ...
Illusory palinopsia is a dysfunction of visual perception, resulting from diffuse, persistent alterations in neuronal excitability that affect physiological mechanisms of light or motion perception. Illusory palinopsia is caused by migraines, visual snow, HPPD, prescription drugs, head trauma, or may be idiopathic.
This condition typically causes sudden vision loss in one eye without any pain. Also Read: Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs .
Most commonly associated with cataract surgery and certain medications, such as sildenafil, cyanopsia is typically a temporary side effect rather than a standalone disease. The condition primarily affects the retina, the light-sensitive layer at the back of the eye, and sometimes the optic nerve, which transmits visual signals to the brain.
A review and meta-analysis published in Neuroscience and Biobehavioral Reviews in May 2024 highlighted the benefits that prescription drugs for ADHD can bring to brain health.